1. Home
  2. TKLF vs ASBP Comparison

TKLF vs ASBP Comparison

Compare TKLF & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TKLF

Yoshitsu Co. Ltd

HOLD

Current Price

$1.75

Market Cap

8.3M

ML Signal

HOLD

Logo Aspire Biopharma Holdings Inc.

ASBP

Aspire Biopharma Holdings Inc.

HOLD

Current Price

$7.97

Market Cap

6.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TKLF
ASBP
Founded
2006
2021
Country
Japan
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.3M
6.8M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
TKLF
ASBP
Price
$1.75
$7.97
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.9K
26.6K
Earning Date
12-19-2025
04-08-2026
Dividend Yield
10.97%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.82
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.69
$0.05
52 Week High
$4.32
$8.18

Technical Indicators

Market Signals
Indicator
TKLF
ASBP
Relative Strength Index (RSI) 38.12 61.10
Support Level $1.78 $0.16
Resistance Level $2.39 N/A
Average True Range (ATR) 0.09 0.54
MACD -0.02 0.03
Stochastic Oscillator 25.01 96.38

Price Performance

Historical Comparison
TKLF
ASBP

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd is a retailer and wholesaler of Japanese beauty and health products, sundry products, electronic products, and other products. It sells its products through directly operated physical stores, online stores, and franchise stores and wholesale customers. It operates through directly operated physical stores, online stores and services, and franchise stores and wholesale customers segments, with the franchise stores and wholesale customers segment generating maximum revenue. Geographically, it generates maximum revenue from Hong Kong.

About ASBP Aspire Biopharma Holdings Inc.

Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.

Share on Social Networks: